View All Team
Murry Alper

Murry Alper

Chief Officer Commercial Markets
Clinical Simulations & Medical Communications

Murry Alper
Chief Officer Commercial Markets
Clinical Simulations & Medical Communications

About Murry

Murry Alper brings almost 30 years of experience in the Life Sciences industry, with experience at both major manufacturers, as well as on the agency side. Murry founded Caravel Group in 2006 after a decade in marketing and sales roles at Bristol-Myers Squibb and Genentech. He has co-founded multiple medical communications agencies and was Managing Partner of Compass Group Partners upon its purchase by QHP Capital in June of 2023. Murry joins Simulations Plus as part of its purchase of Pro-ficiency in June of 2024.

Murry has a passion for delivering innovative solutions specific to the strategic opportunities of each client. Strengths of experience and solutions include HCP education, Thought Leader management, and marketplace & customer insights.

Latest Simulations Plus Research
Parameterization of Physiologically Based Biopharmaceutics Models: Workshop Summary Report
Parameterization of Physiologically Based Biopharmaceutics Models: Workshop Summary Report
Pepin X, Arora S, Borges L, Cano-Vega M, Carducci T, Chatterjee P, Chen G, Cristofoletti R, Dallmann A, Delvadia P, Dressman J, Fotaki N, Gray E, Heimbach T, Holte O, Kijima S, Kotzagiorgis E, Lennernäs H, Lindahl A, Loebenberg R, Mackie C, Malamatari M, McAllister M, Mitra A, Moody R, Mudie D, Musuamba Tshinanu F, Polli JE, Rege B, Ren X, Rullo G, Scherholz ML, Song I, Stillhart C, Suarez-Sharp S, Tannergren C, Tsakalozou E, Veerasingham S, Wagner C